Recent studies support this idea by showing, for example, that combination of radiotherapy with pan-Bcl-2 inhibitors ABT-737 and ABT-263 can kill breast and small cell lung cancer cells in vitro (Table S2) [25,26]. This evidence concerns the gene BCL2 and small cell lung carcinoma.